Denali Capital Acquisition Corp. dismisses Marcum LLP, appoints Marcum Asia as auditor

Semnur Pharmaceuticals, Inc.

Dismissed Marcum LLP as independent auditor effective July 15, 2024, upon Audit Committee recommendation.
Marcum's reports for FY 2023 and 2022 had a going concern explanatory paragraph but no adverse opinion or disagreements.
Appointed Marcum Asia CPAs LLP as new independent auditor for the fiscal year ending December 31, 2024, effective July 15, 2024.
No reportable events or disagreements occurred during the prior two fiscal years and subsequent interim periods.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.